Bio 14
Systems of life are being harnessed for progress much as digital systems have been for the last 50 years. That progress isn’t affecting just health and drug development, it’s revolutionizing food and agriculture, energy, even manufacturing. Our first Techonomy Bio event aims to help all of us to understand how progress in bio and life sciences will change society and business.
New sources of energy, disease fighting bacteria, genetic road maps, synthetic foods, pollution detecting organisms, growing products, personal cancer cures, personalized anything cures, changing one’s DNA, reversing extinction, extending life – all are possibilities.
Bio 14
Systems of life are being harnessed for progress much as digital systems have been for the last 50 years. That progress isn’t affecting just health and drug development, it’s revolutionizing food and agriculture, energy, even manufacturing. Our first Techonomy Bio event aims to help all of us to understand how progress in bio and life sciences will change society and business.
New sources of energy, disease fighting bacteria, genetic road maps, synthetic foods, pollution detecting organisms, growing products, personal cancer cures, personalized anything cures, changing one’s DNA, reversing extinction, extending life – all are possibilities.
Come join Stewart Brand of the Long Now Foundation, Drew Endy of Stanford University, Jim Flatt of Synthetic Bio, Andrew Hessel of Autodesk, Ellen Jorgensen of Genspace, Eri Gentry of the Institute for the Future, Floyd Romesberg of Scripps, Beth Seidenberg of Kleiner Perkins Caufield & Byers, Steve Jurvetson of Draper Fisher Jurvetson and others for a half day conversation about technology’s impact on the rapidly accelerating, world changing progress in bio and life sciences.
Speakers
All Sessions
Play all 9 sessionsSystems of Life Impact Business and Society
Exploration, experimentation, and innovation. All fabulous pursuits in their own rights, but what about real-world application? From food to fuel, what are people doing with all these new bio discoveries? In this video, David Kirkpatrick moderates a discussion with Stewart Brand of The Long Now Foundation, Jim Flatt of Genovia Bio and Synthetic Genomics, Inc., Steve Levine of Dassault Systèmes, and Floyd Romesberg of The Scripps Research Institute. Kirkpatrick: So I want to bring the panel up. We’re now going to pick up on a lot of the threads that Nancy has just sort of put into the fabric and continue the discussion of big picture here—what it all means, where it’s all going, what some of the big new opportunities are going to be. An extraordinary group of people up here. I’ll quickly introduce them and then I’m going to talk to them in a variety of ways here. But starting here, Floyd Romesberg has been in the news a lot. He recently created a new kind of life that could never have existed on the planet before by adding what he called X and Y element to the language of DNA and got an E. coli cell to reproduce. So that’s a pretty big deal, and I’m going to ask him a little bit of what that means in a second. He’s at the Scripps Institute in San Diego. Next, Stewart Brand, who, as I said, is sort of a spiritual father for us at Techonomy, of many things, but certainly he’s got a...
Read More
Systems of Life Impact Business and Society
How Will Biological Progress Transform the World?
Participatory Biology
A Life in Bio
Cancer Drugs: Better, Faster, Cheaper
Cancer: Building a Better Mousetrap
Engineering Biology to Address Global Challenges
Programmable Life
Welcome to Techonomy Bio
Agenda
Registration Opens
Welcome
David Kirkpatrick
Founder and Editor-in-Chief, Techonomy
Better, Faster, Cheaper
To beat cancer we need more targeted drugs, made faster, made cheaper. And that means we need to fix the way cancer drugs are made. Here's how. Presentation by:
How Will Biological Progress Transform the World?
With advances in biological and genomic sciences accelerating at an ever-increasing pace, what does the future hold? If biological progress is indeed advancing more rapidly than Moore’s Law, as many assert, what are the economic and societal implications?
Drew Endy
Associate Professor, Bioengineering, Stanford University
Participatory Biology
Just as the Internet leveled the playing field for entrepreneurship, politics and social engagement, recent advances are leveling it for biological progress. Processing power, the cloud and Internet connectivity open doors for inquisitive individuals and nascent biotech startups. How are ordinary people involving themselves in biology, and what will be their impact?
Eri Gentry
Technology Horizons Research Manager, Institute for the Future
David Haussler
Director, Center for Biomolecular Science and Engineering, UC Santa Cruz
David Kirkpatrick
Founder and Editor-in-Chief, Techonomy
A Life in Bio
180 seconds to turn 180 degrees. Reimagine. Reconsider. Rethink.
David Kirkpatrick
Founder and Editor-in-Chief, Techonomy
The Funding Dilemma
Bio-innovators and entrepreneurs are often frustrated that investors don’t see the scope of biological opportunity. The industry's funding models remain in flux. With appetite for risk unpredictable and a landscape that’s often unexplored, what’s a startup to do? How are big companies responding?
Lindy Fishburne
Executive Director, Breakout Labs
Steve Jurvetson
Partner, DFJ
Paul Gurney
Associate Partner, McKinsey & Company
The Razor's Edge
How knife edge scanning helps drive bio discovery.
Presentation by:
Todd Huffman
Chief Executive Officer, 3Scan
Programmable Life
Synthetic biology opens new doors on what life can be, and do. How will we utilize the awesome new tools at our disposal?
Ellen Jorgensen
Co-founder and Executive Director, Genspace
Ryan Phelan
Executive Director and Co-founder, Revive & Restore
Andrew Hessel
Distinguished Research Scientist, Autodesk
Engineering Biology to Address Global Challenges
A look at the economic, social and regulatory implications.
Presentation by:
Systems of Life Impact Business and Society
Exploration, experimentation and innovation. All fabulous pursuits in their own rights, but what about real-world application? From food to fuel, what are people doing with all these new bio discoveries
Stewart Brand
Co-founder, Global Business Network
Jim Flatt
President, Genovia Bio, Synthetic Genomics, Inc.
Steve Levine
Chief Strategy Officer, Dassault Systèmes
Floyd Romesberg
Associate Professor, Chemistry, The Scripps Research Institute
David Kirkpatrick
Founder and Editor-in-Chief, Techonomy
Closing Remarks
David Kirkpatrick
Founder and Editor-in-Chief, Techonomy